IRIDEX Statistics
Total Valuation
IRIDEX has a market cap or net worth of $22.43 million. The enterprise value is $20.72 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IRIDEX has 16.99 million shares outstanding. The number of shares has increased by 2.65% in one year.
| Current Share Class | 16.99M |
| Shares Outstanding | 16.99M |
| Shares Change (YoY) | +2.65% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 10.58% |
| Owned by Institutions (%) | 9.95% |
| Float | 11.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| Forward PS | 0.82 |
| PB Ratio | 3.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.84.
| Current Ratio | 1.96 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -105.72% and return on invested capital (ROIC) is -24.89%.
| Return on Equity (ROE) | -105.72% |
| Return on Assets (ROA) | -7.00% |
| Return on Invested Capital (ROIC) | -24.89% |
| Return on Capital Employed (ROCE) | -19.67% |
| Revenue Per Employee | $534,882 |
| Profits Per Employee | -$58,570 |
| Employee Count | 93 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 3.08 |
Taxes
In the past 12 months, IRIDEX has paid $44,000 in taxes.
| Income Tax | 44,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.98% in the last 52 weeks. The beta is 0.65, so IRIDEX's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -34.98% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 52.05 |
| Average Volume (20 Days) | 91,557 |
Short Selling Information
The latest short interest is 272,132, so 1.60% of the outstanding shares have been sold short.
| Short Interest | 272,132 |
| Short Previous Month | 271,895 |
| Short % of Shares Out | 1.60% |
| Short % of Float | 2.41% |
| Short Ratio (days to cover) | 2.49 |
Income Statement
In the last 12 months, IRIDEX had revenue of $49.74 million and -$5.45 million in losses. Loss per share was -$0.33.
| Revenue | 49.74M |
| Gross Profit | 19.65M |
| Operating Income | -3.52M |
| Pretax Income | -10.73M |
| Net Income | -5.45M |
| EBITDA | -3.25M |
| EBIT | -3.52M |
| Loss Per Share | -$0.33 |
Full Income StatementBalance Sheet
The company has $6.78 million in cash and $5.07 million in debt, giving a net cash position of $1.71 million or $0.10 per share.
| Cash & Cash Equivalents | 6.78M |
| Total Debt | 5.07M |
| Net Cash | 1.71M |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | 6.06M |
| Book Value Per Share | 0.00 |
| Working Capital | 13.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.86 million and capital expenditures -$34,000, giving a free cash flow of -$5.89 million.
| Operating Cash Flow | -5.86M |
| Capital Expenditures | -34,000 |
| Free Cash Flow | -5.89M |
| FCF Per Share | -$0.35 |
Full Cash Flow StatementMargins
Gross margin is 39.49%, with operating and profit margins of -7.07% and -10.95%.
| Gross Margin | 39.49% |
| Operating Margin | -7.07% |
| Pretax Margin | -10.86% |
| Profit Margin | -10.95% |
| EBITDA Margin | -6.54% |
| EBIT Margin | -7.07% |
| FCF Margin | n/a |
Dividends & Yields
IRIDEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.65% |
| Shareholder Yield | -2.65% |
| Earnings Yield | -24.28% |
| FCF Yield | -26.26% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRIDEX has an Altman Z-Score of -1.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.72 |
| Piotroski F-Score | 2 |
